John Hamm

Insider Reports History

Location: 2525 West End Avenue, Suite 950, Nashville, TN
Signature: /s/ John Hamm
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Hamm:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
CUMBERLAND PHARMACEUTICALS INC	VP Chief Financial Officer	Common Stock	20.1K	$110K	$5.46	Mar 16, 2025	Direct
CUMBERLAND PHARMACEUTICALS INC	VP Chief Financial Officer	Options (right to buy)	15.3K	$78.8K	$5.17	Mar 17, 2025	Direct

Showing 1 to 2 of 2 entries

Insider Reports Filed by John Hamm

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
CPIX	CUMBERLAND PHARMACEUTICALS INC	Mar 16, 2025	2	-$18.2K	4	Mar 18, 2025	VP Chief Financial Officer
CPIX	CUMBERLAND PHARMACEUTICALS INC	Mar 23, 2024	2	$8.6K	4	Mar 26, 2024	VP Chief Financial Officer
CPIX	CUMBERLAND PHARMACEUTICALS INC	Nov 27, 2023	1	-$588	4	Dec 6, 2023	Chief Financial Officer
CPIX	CUMBERLAND PHARMACEUTICALS INC	Mar 24, 2023	1	$0	4	Mar 27, 2023	Chief Financial Officer
CPIX	CUMBERLAND PHARMACEUTICALS INC	Mar 16, 2022	2	$51.8K	4	Apr 29, 2022	Chief Financial Officer
CPIX	CUMBERLAND PHARMACEUTICALS INC	Nov 23, 2021	1	$8.93K	4	Dec 3, 2021	Chief Financial Officer
CPIX	CUMBERLAND PHARMACEUTICALS INC	May 17, 2021	0	$0	3	Jul 9, 2021	Chief Financial Officer